Current Trends and Limitations in Dengue Antiviral Research
Dengue is the most prevalent arthropod-borne viral disease worldwide and affects approximately 2.5 billion people living in over 100 countries. Increasing geographic expansion of <i>Aedes aegypti</i> mosquitoes (which transmit the virus) has made dengue a global health concern. There are...
Main Authors: | Juliet O. Obi, Hernando Gutiérrez-Barbosa, Joel V. Chua, Daniel J. Deredge |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2021-09-01
|
Series: | Tropical Medicine and Infectious Disease |
Subjects: | |
Online Access: | https://www.mdpi.com/2414-6366/6/4/180 |
Similar Items
-
The experience in treatment of dengue fever using antiviral drug riamilovir in the Republic of Guinea (case report)
by: Oleg V. Maltsev, et al.
Published: (2023-02-01) -
Lipophilic Nucleoside Triphosphate Prodrugs of Anti‐HIV Active Nucleoside Analogs as Potential Antiviral Compounds
by: Xiao Jia, et al.
Published: (2023-12-01) -
Probing the Effects of Pyrimidine Functional Group Switches on Acyclic Fleximer Analogues for Antiviral Activity
by: Mary K. Yates, et al.
Published: (2019-09-01) -
Antiviral Agents against Flavivirus Protease: Prospect and Future Direction
by: Subodh K. Samrat, et al.
Published: (2022-02-01) -
Identification of Novel Non-Nucleoside Inhibitors of Zika Virus NS5 Protein Targeting MTase Activity
by: Diego Fiorucci, et al.
Published: (2024-02-01)